Hoilett, O. S. | bioRxiv Science

bioRxiv2025

Electrochemical Paper Fluidic Device for Extended Real-time Cocaine Monitoring in Simulated Sweat

Cocaine and other illicit substances are known to excrete from the body into sweat, making sweat an advantageous matrix for non-invasive detection and monitoring of substance use and abuse. However, existing detection of illicit substances in sweat remain single-use technologies that arent suitable for real-time, continuous monitoring over the course of an entire day. Long-term, continuous detection is hampered by large, bulky instrumentation, limited sensor stability for multi-hour measurements, and fluidic systems not optimized for minute and variable sweat flow rates. We demonstrate the continuous detection of 0.5 mM cocaine in simulated sweat via a paper fluidic device over the course of 17 hours. Our sensing system uses a biosensor functionalized with a cocaine-binding aptamer and a miniaturized electrochemical potentiostat. Our fluidics are driven by evaporation flow at physiological sweat rates (0.3-0.5 {micro}L/min/cm2). Our development lays critical groundwork towards wearable, continuous detection of illicit substances in sweat.

biochemistry↗

bioRxiv2019

Microfluidic Rapid and Autonomous Analytical Device (microRAAD) to Detect HIV from Whole Blood Samples

Early Human Immunodeficiency Virus (HIV) testing is critical to preventing transmission and providing treatment to HIV-positive individuals, yet an estimated 30% of HIV-positive individuals do not know their status because of barriers to early diagnosis. Readily accessible, highly sensitive, and rapid diagnostic tests would enable patients prompt treatment with anti-retroviral therapies and reduce transmission. However, existing HIV diagnostic technologies either do not detect early stages of infection or require multiple days of laboratory processing, delaying notification of patients status.\n\nMolecular techniques that amplify HIV RNA can detect the earliest stages of infection, within 8-10 days after transmission. However, most of these molecular assays require cold-chain storage of reagents, significant sample preparation, and extensive laboratory infrastructure. To achieve early detection, we developed a reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay with a limit of detection of 10 HIV-1 RNA copies visualized by eye using a lateral flow immunoassay. To demonstrate automated sample-to-answer detection of HIV, we incorporate dried amplification reagents and wax valves in low-cost substrates with resistive heating elements and circuitry. By combining controlled heating with papers capillary flow, our assembled device automatically isolates viral particles from human blood samples, amplifies HIV-1 RNA, and transports products to a detection zone. We determine that as few as 105 HIV-1 viral particles can be separated from whole blood, amplified, and visually detected within 90 minutes of sample addition into our Microfluidic Rapid and Autonomous Analysis Device (microRAAD). The low-cost and automated attributes of microRAAD demonstrate its utility as a point-of-care testing platform.

bioengineering↗